tiprankstipranks
Trending News
More News >
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
Advertisement

Atea Pharmaceuticals (AVIR) Technical Analysis

Compare
222 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Atea Pharmaceuticals’s (AVIR) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Atea Pharmaceuticals is a Buy.
Atea Pharmaceuticals’s (AVIR) 20-Day exponential moving average is 3.51, while Atea Pharmaceuticals’s (AVIR) share price is $3.36, making it a Sell.
Atea Pharmaceuticals’s (AVIR) 50-Day exponential moving average is 3.32, while Atea Pharmaceuticals’s (AVIR) share price is $3.36, making it a Buy.

Atea Pharmaceuticals (AVIR) Pivot Points

Jul 20, 2025, 09:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.32
3.38
3.42
3.47
3.51
3.57
3.61
Fibonacci
3.38
3.41
3.44
3.47
3.51
3.53
3.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atea Pharmaceuticals (AVIR) Moving Averages

Jul 20, 2025, 09:37 AM
Period
Simple
Exponential
MA5
3.53Sell
3.49Sell
MA10
3.61Sell
3.55Sell
MA20
3.56Sell
3.51Sell
MA50
3.21Buy
3.32Buy
MA100
3.09Buy
3.21Buy
MA200
3.18Buy
3.28Buy
Atea Pharmaceuticals’s (AVIR) 10-Day exponential moving average is 3.55, while Atea Pharmaceuticals’s (AVIR) share price is $3.36, making it a Sell.
Atea Pharmaceuticals’s (AVIR) 100-Day exponential moving average is 3.21, while Atea Pharmaceuticals’s (AVIR) share price is $3.36, making it a Buy.
Atea Pharmaceuticals’s (AVIR) stock price is $3.36 and Atea Pharmaceuticals’s (AVIR) 50-day simple moving average is 3.21, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.36 and Atea Pharmaceuticals’s (AVIR) 100-day simple moving average is 3.09, creating a Buy signal.
Atea Pharmaceuticals’s (AVIR) stock price is $3.36 and Atea Pharmaceuticals’s (AVIR) 200-day simple moving average is 3.18, creating a Buy signal.

Atea Pharmaceuticals (AVIR) Technical Indicators

Jul 20, 2025, 09:37 AM
Name
Value
Implied Action
RSI (14)
44.90
Neutral
STOCH (9,6)
5.27
Buy
STOCHRSI (14)
8.33
Buy
MACD (12,26)
0.08
Buy
ADX (14)
37.62
Neutral
Williams %R
-100.00
Buy
CCI (14)
-82.99
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
24.25
Sell
ROC
-2.61
Sell
Atea Pharmaceuticals’s (AVIR) Relative Strength Index (RSI) is 44.90, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Trend Strength Indicator (ADX) is 37.62, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Commodity Channel Index (CCI) is -82.99, creating a Neutral signal.
Atea Pharmaceuticals’s (AVIR) Price Rate of Change (ROC) is -2.61, creating a Sell signal.

FAQ

Is AVIR a Buy, Hold, or Sell?
Based on AVIR’s technical indicators, AVIR is a Hold.
    What is AVIR’s RSI (14)?
    AVIR’s RSI (14) is 44.90, which suggests AVIR is a Neutral.
      What is AVIR’s MACD?
      AVIR’s MACD is 0.08, which suggests AVIR is a Buy.
        What is AVIR’s 5-day moving average?
        AVIR’s 5-day moving average is 3.53, which suggests AVIR is a Sell.
          What is AVIR’s 20-day moving average?
          AVIR 20-day moving average is 3.56, which suggests AVIR is a Sell.
            What is AVIR’s 50-day moving average?
            AVIR’s 50-day moving average is 3.21, which suggests AVIR is a Buy.
              What is AVIR’s 200-day moving average?
              AVIR’s 200-day moving average is 3.18, which suggests AVIR is a Buy.
                What is AVIR’s Williams % R (14)?
                AVIR’s Williams % R (14) is -100.00, which suggests AVIR is a Buy.
                  What is AVIR’s CCI (14)?
                  AVIR’s CCI (14) is -82.99, which suggests AVIR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis